Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences

Friedemann Paul; Dennis Bourdette

doi:10.1212/01.wnl.0000435305.95271.84

Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences

Friedemann Paul, Dennis Bourdette

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1648-1649
Number of pages	2
Journal	Neurology
Volume	81
Issue number	19
DOIs	https://doi.org/10.1212/01.wnl.0000435305.95271.84
State	Published - Nov 5 2013
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/01.wnl.0000435305.95271.84

Cite this

@article{c6a7f8aa364e4734b47e0a3b8e7ddde1,

title = "Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences",

author = "Friedemann Paul and Dennis Bourdette",

year = "2013",

month = nov,

day = "5",

doi = "10.1212/01.wnl.0000435305.95271.84",

language = "English (US)",

volume = "81",

pages = "1648--1649",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "19",

}

TY - JOUR

T1 - Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences

AU - Paul, Friedemann

AU - Bourdette, Dennis

PY - 2013/11/5

Y1 - 2013/11/5

UR - http://www.scopus.com/inward/record.url?scp=84888234144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888234144&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000435305.95271.84

DO - 10.1212/01.wnl.0000435305.95271.84

M3 - Editorial

C2 - 24097812

AN - SCOPUS:84888234144

SN - 0028-3878

VL - 81

SP - 1648

EP - 1649

JO - Neurology

JF - Neurology

IS - 19

ER -

Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this